ATAD2 and cancer: A subset of ERGs was frequently genetically altered across many malignancies (SNAs in the KMT2A/B/C/D family members and ARID1A, and deep CNAs in BOP1 and ATAD2 were each seen in several cancer types), consistent with the notion that disruption of some ERGs represents a shared driver mechanism operating across multiple cancer types.